Truvestments Capital’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.85K Hold
170
– – ﹤0.01% 830
2026
Q1
$5.63K Hold
170
– – ﹤0.01% 863
2025
Q4
$5.56K Hold
170
– – ﹤0.01% 791
2025
Q3
$3.03K Hold
170
– – ﹤0.01% 888
2025
Q2
$1.84K Hold
170
– – ﹤0.01% 849
2025
Q1
$3.15K Hold
170
– – ﹤0.01% 811
2024
Q4
$2.8K Hold
170
– – ﹤0.01% 785
2024
Q3
$2.38K Buy
+170
New +$1.88K ﹤0.01% 777
2024
Q2
– Sell
-170
Closed -$1.37K – 262
2024
Q1
$1.37K Hold
170
– – ﹤0.01% 635
2023
Q4
$1.16K Hold
170
– – ﹤0.01% 702
2023
Q3
$850 Hold
170
– – ﹤0.01% 630
2023
Q2
$1.55K Hold
170
– – ﹤0.01% 614
2023
Q1
$1.61K Hold
170
– – ﹤0.01% 590
2022
Q4
$1.7K Hold
170
– – ﹤0.01% 756
2022
Q3
$2K Hold
170
– – ﹤0.01% 542
2022
Q2
$1K Buy
+170
New +$1.45K ﹤0.01% 590
2022
Q1
– Sell
-170
Closed -$2K – 213
2021
Q4
$2K Hold
170
– – ﹤0.01% 545
2021
Q3
$3K Hold
170
– – ﹤0.01% 498
2021
Q2
$4K Hold
170
– – ﹤0.01% 479
2021
Q1
$3K Buy
+170
New +$3.36K ﹤0.01% 562

Other funds holding AXGN

Truvestments Capital's AXGN Position: Q2 2026 in Review

Truvestments Capital held its Axogen (AXGN) position steady in Q2 2026 at 170 shares worth $7.85K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Truvestments Capital first reported a position in AXGN in Q1 2021 and has held it in 20 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Truvestments Capital held 170 shares of Axogen worth $7.85K as of Q2 2026.
  • Truvestments Capital left its Axogen share count unchanged in Q2 2026.
  • Axogen made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #830 holding.
  • Truvestments Capital first reported a position in Axogen in Q1 2021 and has held it in 20 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.